A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform()()

Immunomodulatory drugs such as lenalidomide (LEN) have shown significant anti-tumor activity against hematologic malignancies and they may have similar actions on solid tumors as well. We studied the effect of a new analog of the immunomodulatory drugs (CC-122) on the growth of hepatocellular carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomimaru, Yoshito, Aihara, Arihiro, Wands, Jack R., Aloman, Costica, Kim, Miran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664230/
https://www.ncbi.nlm.nih.gov/pubmed/31352197
http://dx.doi.org/10.1016/j.tranon.2019.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664230/
https://www.ncbi.nlm.nih.gov/pubmed/31352197
http://dx.doi.org/10.1016/j.tranon.2019.07.002

Ejemplares similares